-1.8 C
Munich
Monday, January 24, 2022

PharmEasy initiates Covid-19 vaccination drive, Health News, ET HealthWorld

Must read

[ad_1]

While the government has set an ambitious target, technical issues continue to dog phase 2 of the vaccination drive in the Mysuru region.
While the government has set an ambitious target, technical issues continue to dog phase 2 of the vaccination drive in the Mysuru region.

Mumbai, April 24, 2021: PharmEasy, has launched the biggest Covid-19 vaccination drive in the country. With this drive, the company aims to vaccinate over 3 crore people via camps and vaccine centres. Individuals, companies, RWAs, Old Age Homes etc. can register for vaccines that will be administered.

India has witnessed a record rise in Covid-19 cases due to the second wave, surpassing the worst of last year. Given the current situation, the Government of India has invited the participation of private companies to accelerate vaccination across the country. From 1st May 2021, wherein all legal adults (above the age of 18) will be eligible to get vaccinated against Covid-19.

PharmEasy has extended its support in furthering the clarion call of “Teeka Utsav” given by the Hon’ble Prime Minister, Shri Narendra Modi. Leveraging its presence across India, with over 80,000 partner retailers, 5,000 doctors and a state-of-the-art pharma supply chain facility enabling last-mile delivery of cold chain products, the company aims to vaccinate over 3 crore families via 5,000 partner centres, pan-India in the next few quarters.
Speaking about the vaccination drive, Dharmil Sheth, Co-founder, PharmEasy said, “We want to be a vital part of the government’s vaccination drive and help accelerate the process of mass vaccination. Our vaccination drive aims to provide ease of access to vaccination which can help us to achieve herd immunity at the earliest. Amidst the rising COVID-19 cases in the second wave, we wanted to contribute our bit in breaking the chain by setting up vaccination camps and centres to facilitate this.”



[ad_2]

Source link

- Advertisement -spot_img

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article